Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02960555
Title Trial of Isatuximab (SAR650984) in Patients With High Risk Smoldering Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

smoldering myeloma


Diphenhydramine + Isatuximab + Methylprednisolone + Ranitidine

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.